Tomsitz相关文献与解析，生知库 | 链接生命科学的每一步

Tomsitz, Dirk; Livingstone, Elisabeth; Loquai, Carmen; Kaatz, Martin; Leiter, Ulrike; Schilling, Bastian; Terheyden, Patrick; Hassel, Jessica; Sachse, Michael; Ulrich, Jens; Dippel, Edgar; Meiss, Frank; Pföhler, Claudia; Kreuter, Alexander; Herbst, Rudolf; Weichenthal, Michael; Zimmer, Lisa; Meier, Friedegund; Rauschenberg, Ricarda; Mohr, Peter; Brunnert, Fiona; von Wasielewski, Imke; Gutzmer, Ralf; Schadendorf, Dirk; Berking, Carola; Ugurel, Selma; Heinzerling, Lucie

黑色素瘤

免疫/内分泌

发表日期：2025

文献求助收藏

Real-world management and outcomes of immune-related adverse events in German cancer care: A multicenter analysis using the SERIO registry

德国癌症治疗中免疫相关不良事件的真实世界管理和结局：一项基于SERIO注册库的多中心分析

期刊:Oncologist

影响因子:4.2

doi:10.1093/oncolo/oyaf275

Ertl, Carolin; Tomsitz, Dirk; Rizzo, Filippo; Hempel, Dirk; Heinzerling, Lucie; Milani, Valeria

CDK4/6 inhibitor in combination with aromatase inhibitor effective in metastatic hidradenocarcinoma

CDK4/6抑制剂联合芳香化酶抑制剂对转移性汗腺癌有效

期刊:Journal Der Deutschen Dermatologischen Gesellschaft

影响因子:3.8

doi:10.1111/ddg.15723

Glatzel, Valerie; Tomsitz, Dirk; Maurer, Michaela; Schneider, Simone; Brunner, Stefan; Harbeck, Nadia; Heinzerling, Lucie

Successful treatment of localized Merkel cell carcinoma with avelumab in a patient with amyotrophic lateral sclerosis

阿维鲁单抗成功治疗肌萎缩侧索硬化症患者的局限性默克尔细胞癌

期刊:Immunotherapy

影响因子:2.3

doi:10.1080/1750743X.2025.2554566

Arnold, Lisa; Tomsitz, Dirk; Buchillon, Raquel; Leding, Julia; Senner, Sonja; Frey, Surina; Janjic, Nina; French, Lars E; Heinzerling, Lucie

Stringent monitoring can decrease mortality of immune checkpoint inhibitor induced cardiotoxicity

严格的监测可以降低免疫检查点抑制剂引起的心脏毒性的死亡率。

期刊:Frontiers in Cardiovascular Medicine

影响因子:2.9

doi:10.3389/fcvm.2024.1408586

Wang, Ying; Ertl, Carolin; Schmitt, Christina; Hammann, Linda; Kramer, Rafaela; Grabmaier, Ulrich; Schöberl, Florian; Anz, David; Piseddu, Ignazio; Pesch, Giulia; Vera, Julio; Froehlich, Waltraud; Weckbach, Ludwig; Tomsitz, Dirk; Loquai, Carmen; Zimmer, Lisa; Mangana, Johanna; Dummer, Reinhard; Gutzmer, Ralf; Klespe, Kai-Christian; Stege, Henner; Meiss, Frank; Thoms, Kai-Martin; Terheyden, Patrick; Bröckelmann, Paul J; Johnson, Douglas B; French, Lars E; Heinzerling, Lucie

Cost-effectiveness of Response-Adapted De-escalation of Immunotherapy in Advanced Melanoma

晚期黑色素瘤免疫疗法反应适应性降阶治疗的成本效益分析

期刊:Jama Dermatology

影响因子:11

doi:10.1001/jamadermatol.2022.4556

Cartun, Zachary; Kunz, Wolfgang G; Heinzerling, Lucie; Tomsitz, Dirk; Guertler, Anne; Westphalen, C Benedikt; Ricke, Jens; Weir, William; Unterrainer, Marcus; Mehrens, Dirk

Checkpoint-inhibitor induced Polyserositis with Edema

检查点抑制剂诱发的多浆膜炎伴水肿

期刊:Cancer Immunology Immunotherapy

影响因子:5.1

doi:10.1007/s00262-022-03211-7

Zierold, Sarah; Akcetin, Larissa Semra; Gresser, Eva; Maier, Anna Marie; König, Alexander; Kramer, Rafaela; Theurich, Sebastian; Tomsitz, Dirk; Erdmann, Michael; French, Lars E; Rudelius, Martina; Heinzerling, Lucie

Checkpoint

发表日期：2022

文献求助收藏

Development of Lymphopenia during Therapy with Immune Checkpoint Inhibitors Is Associated with Poor Outcome in Metastatic Cutaneous Melanoma

免疫检查点抑制剂治疗期间淋巴细胞减少症的发生与转移性皮肤黑色素瘤预后不良相关

期刊:Cancers

影响因子:4.4

doi:10.3390/cancers14133282

Tomsitz, Dirk; Schlaak, Max; Zierold, Sarah; Pesch, Giulia; Schulz, Thomas U; Müller, Genoveva; Zecha, Christine; French, Lars E; Heinzerling, Lucie

Health-related quality of life (EuroQol 5D-5L) in patients with autoimmunity in the context of immunotherapy: A large dataset comprising cancer patients after cessation of checkpoint inhibitor therapy and patients with autoimmune diseases

免疫治疗背景下自身免疫性疾病患者的健康相关生活质量（EuroQol 5D-5L）：一项包含停止免疫检查点抑制剂治疗后的癌症患者和自身免疫性疾病患者的大型数据集

期刊:Data in Brief

影响因子:1.4

doi:10.1016/j.dib.2022.108676

Schulz, Thomas U; Zierold, Sarah; Sachse, Michael M; Pesch, Giulia; Tomsitz, Dirk; Schilbach, Katharina; Kähler, Katharina C; French, Lars E; Heinzerling, Lucie

Cofactors of wheat-dependent exercise-induced anaphylaxis do not increase highly individual gliadin absorption in healthy volunteers

小麦依赖性运动诱发过敏反应的辅助因子不会显著增加健康志愿者对麦醇溶蛋白的吸收。

期刊:Clinical and Translational Allergy

影响因子:4

doi:10.1186/s13601-019-0260-0

Scherf, Katharina Anne; Lindenau, Ann-Christin; Valentini, Luzia; Collado, Maria Carmen; García-Mantrana, Izaskun; Christensen, Morten; Tomsitz, Dirk; Kugler, Claudia; Biedermann, Tilo; Brockow, Knut

发表日期：2019

文献求助收藏

Early termination does not negatively impact the outcome of adjuvant immunotherapy in melanoma

提前终止治疗不会对黑色素瘤辅助免疫疗法的疗效产生负面影响。

Real-world management and outcomes of immune-related adverse events in German cancer care: A multicenter analysis using the SERIO registry

德国癌症治疗中免疫相关不良事件的真实世界管理和结局：一项基于SERIO注册库的多中心分析

CDK4/6 inhibitor in combination with aromatase inhibitor effective in metastatic hidradenocarcinoma

CDK4/6抑制剂联合芳香化酶抑制剂对转移性汗腺癌有效

Successful treatment of localized Merkel cell carcinoma with avelumab in a patient with amyotrophic lateral sclerosis

阿维鲁单抗成功治疗肌萎缩侧索硬化症患者的局限性默克尔细胞癌

Stringent monitoring can decrease mortality of immune checkpoint inhibitor induced cardiotoxicity

严格的监测可以降低免疫检查点抑制剂引起的心脏毒性的死亡率。

Cost-effectiveness of Response-Adapted De-escalation of Immunotherapy in Advanced Melanoma

晚期黑色素瘤免疫疗法反应适应性降阶治疗的成本效益分析

Checkpoint-inhibitor induced Polyserositis with Edema

检查点抑制剂诱发的多浆膜炎伴水肿

Development of Lymphopenia during Therapy with Immune Checkpoint Inhibitors Is Associated with Poor Outcome in Metastatic Cutaneous Melanoma

免疫检查点抑制剂治疗期间淋巴细胞减少症的发生与转移性皮肤黑色素瘤预后不良相关

Health-related quality of life (EuroQol 5D-5L) in patients with autoimmunity in the context of immunotherapy: A large dataset comprising cancer patients after cessation of checkpoint inhibitor therapy and patients with autoimmune diseases

免疫治疗背景下自身免疫性疾病患者的健康相关生活质量（EuroQol 5D-5L）：一项包含停止免疫检查点抑制剂治疗后的癌症患者和自身免疫性疾病患者的大型数据集

Cofactors of wheat-dependent exercise-induced anaphylaxis do not increase highly individual gliadin absorption in healthy volunteers

小麦依赖性运动诱发过敏反应的辅助因子不会显著增加健康志愿者对麦醇溶蛋白的吸收。